Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00298883 · ClinicalTrials.gov registry record · Phase 1
Desensitization of Renal Transplant Candidates
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT00298883 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 9 participants.
The verdict
NCT00298883, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Trial of the use of Myfortic to reduce anti-HLA alloantibody in patients waiting for renal transplantation.
Interventions
- DRUG Myfortic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00298883
The ClinicalTrials.gov registry entry for NCT00298883 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Myfortic is the first listed.
NCT00298883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00298883 about?
NCT00298883 is a clinical study titled "Desensitization of Renal Transplant Candidates". Trial of the use of Myfortic to reduce anti-HLA alloantibody in patients waiting for renal transplantation.
What is the current status of trial NCT00298883?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2006-02. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00298883?
The interventions under investigation include: Myfortic (DRUG).
Who is sponsoring clinical trial NCT00298883?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.